Condition: Cancer Diagnosis · Sponsor: European Institute of Oncology
The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.
This description comes directly from the study's public registry record.
Gabriella Pravettoni, MD · +390257489731 · gabriella.pravettoni@ieo.it
Always discuss trial participation with your own doctor first.
| Centre François Baclesse | Caen, France | Recruiting |
| Saarland University | Homburg, Germany | Not Yet Recruiting |
| European Institute of Oncology | Milan, Italy, Italy | Not Yet Recruiting |
| National Cancer Institute | Vilnius, Lithuania | Not Yet Recruiting |
| Catalan Institute of Oncology | Barcelona, Spain | Not Yet Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.